Related Experiment Videos
Fluconazole inhibits pseudohyphal growth in Saccharomyces cerevisiae
1Section of Infectious Diseases, Department of Internal Medicine Specialties, The University of Texas M.D. Anderson Cancer Center, Houston, Tex., USA. dkontoyi@notes.mdacc.tmc.edu
Abstract:
The ergosterol-depleting antifungal fluconazole, when given at concentrations not affecting growth, inhibited pseudohyphal growth in Saccharomyces cerevisiae, a genetically tractable fungus closely related to the human pathogen Candida albicans. These results suggest that S. cerevisiae could serve as a useful genetic system to study the morphogenetic effects induced by azoles in pathogenic yeast.
Insights
The antifungal fluconazole inhibits yeast pseudohyphal growth, even at low doses. This finding suggests Saccharomyces cerevisiae can model azole effects in pathogenic fungi like Candida albicans.
Area of Science:
- Medical Mycology
- Yeast Genetics
Background:
- Azole antifungals are crucial for treating fungal infections.
- Pathogenic yeasts like Candida albicans exhibit morphological changes, such as pseudohyphal growth, which are linked to virulence.
- Understanding the mechanisms of azole-induced morphogenetic changes is important for developing effective therapies.
Purpose of the Study:
- To investigate the effect of fluconazole on pseudohyphal growth in Saccharomyces cerevisiae.
- To determine if Saccharomyces cerevisiae can be used as a model system to study azole-induced morphogenetic effects in pathogenic yeasts.
Main Methods:
- Utilized Saccharomyces cerevisiae, a genetically tractable yeast species.
- Administered fluconazole at sub-inhibitory concentrations (not affecting growth).
- Observed and quantified pseudohyphal growth.
Main Results:
- Fluconazole significantly inhibited pseudohyphal growth in Saccharomyces cerevisiae at concentrations that did not affect overall cell growth.
- This inhibition occurred despite fluconazole's primary mechanism of action targeting ergosterol synthesis.
Conclusions:
- Saccharomyces cerevisiae responds to fluconazole by suppressing pseudohyphal development.
- The results support the use of Saccharomyces cerevisiae as a model organism to study the morphogenetic impacts of azole antifungals on pathogenic yeasts.